Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Short communication: three years follow-up of first-line antiretroviral therapy in cambodia: negative impact of prior antiretroviral treatment.
Ségéral O, Limsreng S, Nouhin J, Hak C, Ngin S, De Lavaissière M, Goujard C, Taburet AM, Nerrienet E, Delfraissy JF, Ouk V, Dulioust A. Ségéral O, et al. Among authors: nerrienet e. AIDS Res Hum Retroviruses. 2011 Jun;27(6):597-603. doi: 10.1089/AID.2010.0125. Epub 2011 Jan 17. AIDS Res Hum Retroviruses. 2011. PMID: 21083413
Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.
Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, Madec Y, Marcy O, Chan S, Prak N, Kim C, Lak KK, Hak C, Dim B, Sin CI, Sun S, Guillard B, Sar B, Vong S, Fernandez M, Fox L, Delfraissy JF, Goldfeld AE; CAMELIA (ANRS 1295–CIPRA KH001) Study Team. Blanc FX, et al. Among authors: nerrienet e. N Engl J Med. 2011 Oct 20;365(16):1471-81. doi: 10.1056/NEJMoa1013911. N Engl J Med. 2011. PMID: 22010913 Free PMC article. Clinical Trial.
Plasma concentrations, efficacy and safety of efavirenz in HIV-infected adults treated for tuberculosis in Cambodia (ANRS 1295-CIPRA KH001 CAMELIA trial).
Borand L, Madec Y, Laureillard D, Chou M, Marcy O, Pheng P, Prak N, Kim C, Lak KK, Hak C, Dim B, Nerrienet E, Fontanet A, Sok T, Goldfeld AE, Blanc FX, Taburet AM. Borand L, et al. Among authors: nerrienet e. PLoS One. 2014 Mar 7;9(3):e90350. doi: 10.1371/journal.pone.0090350. eCollection 2014. PLoS One. 2014. PMID: 24608960 Free PMC article. Clinical Trial.
High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, Cambodia.
Ferradini L, Ouk V, Segeral O, Nouhin J, Dulioust A, Hak C, Fournier I, Lerolle N, Ngin S, Mean CV, Delfraissy JF, Nerrienet E. Ferradini L, et al. Among authors: nerrienet e. J Int AIDS Soc. 2011 Mar 26;14:14. doi: 10.1186/1758-2652-14-14. J Int AIDS Soc. 2011. PMID: 21439074 Free PMC article. Clinical Trial.
Paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome after early initiation of antiretroviral therapy in a randomized clinical trial.
Laureillard D, Marcy O, Madec Y, Chea S, Chan S, Borand L, Fernandez M, Prak N, Kim C, Dim B, Nerrienet E, Sok T, Delfraissy JF, Goldfeld AE, Blanc FX; CAMELIA (ANRS 1295 – CIPRA KH001) Study Team. Laureillard D, et al. Among authors: nerrienet e. AIDS. 2013 Oct 23;27(16):2577-86. doi: 10.1097/01.aids.0000432456.14099.c7. AIDS. 2013. PMID: 24096631 Clinical Trial.
Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study.
Ségéral O, Nerrienet E, Neth S, Spire B, Khol V, Ferradini L, Sarun S, Mom C, Ngin S, Charpentier C, Men P, Mora M, Mean Chhi V, Ly P, Saphonn V. Ségéral O, et al. Among authors: nerrienet e. Front Public Health. 2018 Mar 19;6:63. doi: 10.3389/fpubh.2018.00063. eCollection 2018. Front Public Health. 2018. PMID: 29662875 Free PMC article.
Adherence to PI-based 2nd-line regimens in Cambodia is not simply a question of individual behaviour: the ANRS 12276 2PICAM study.
Sagaon-Teyssier L, Mmadi Mrenda B, Khol V, Ferradini L, Mam S, Ngin S, Mora M, Maradan G, Vun Mean C, Ségéral O, Nerrienet E, Saphonn V, Spire B. Sagaon-Teyssier L, et al. Among authors: nerrienet e. Trop Med Int Health. 2017 Nov;22(11):1428-1435. doi: 10.1111/tmi.12975. Epub 2017 Oct 2. Trop Med Int Health. 2017. PMID: 28905466 Free article.
Natural killer cell degranulation capacity predicts early onset of the immune reconstitution inflammatory syndrome (IRIS) in HIV-infected patients with tuberculosis.
Pean P, Nerrienet E, Madec Y, Borand L, Laureillard D, Fernandez M, Marcy O, Sarin C, Phon K, Taylor S, Pancino G, Barré-Sinoussi F, Scott-Algara D; Cambodian Early versus Late Introduction of Antiretroviral Drugs (CAMELIA) study team. Pean P, et al. Among authors: nerrienet e. Blood. 2012 Apr 5;119(14):3315-20. doi: 10.1182/blood-2011-09-377523. Epub 2012 Feb 17. Blood. 2012. PMID: 22343919 Free article.
87 results